Your browser doesn't support javascript.
loading
The Australian Reproductive Genetic Carrier Screening Project (Mackenzie's Mission): Design and Implementation.
Archibald, Alison D; McClaren, Belinda J; Caruana, Jade; Tutty, Erin; King, Emily A; Halliday, Jane L; Best, Stephanie; Kanga-Parabia, Anaita; Bennetts, Bruce H; Cliffe, Corrina C; Madelli, Evanthia O; Ho, Gladys; Liebelt, Jan; Long, Janet C; Braithwaite, Jeffrey; Kennedy, Jillian; Massie, John; Emery, Jon D; McGaughran, Julie; Marum, Justine E; Boggs, Kirsten; Barlow-Stewart, Kristine; Burnett, Leslie; Dive, Lisa; Freeman, Lucinda; Davis, Mark R; Downes, Martin J; Wallis, Mathew; Ferrie, Monica M; Pachter, Nicholas; Scuffham, Paul A; Casella, Rachael; Allcock, Richard J N; Ong, Royston; Edwards, Samantha; Righetti, Sarah; Lunke, Sebastian; Lewis, Sharon; Walker, Susan P; Boughtwood, Tiffany F; Hardy, Tristan; Newson, Ainsley J; Kirk, Edwin P; Laing, Nigel G; Delatycki, Martin B.
Afiliação
  • Archibald AD; Victorian Clinical Genetics Services, Parkville, VIC 3052, Australia.
  • McClaren BJ; Murdoch Children's Research Institute, Parkville, VIC 3052, Australia.
  • Caruana J; Department of Paediatrics, University of Melbourne, Parkville, VIC 3052, Australia.
  • Tutty E; Murdoch Children's Research Institute, Parkville, VIC 3052, Australia.
  • King EA; Department of Paediatrics, University of Melbourne, Parkville, VIC 3052, Australia.
  • Halliday JL; Murdoch Children's Research Institute, Parkville, VIC 3052, Australia.
  • Best S; Australian Genomics, Parkville, VIC 3052, Australia.
  • Kanga-Parabia A; Murdoch Children's Research Institute, Parkville, VIC 3052, Australia.
  • Bennetts BH; Murdoch Children's Research Institute, Parkville, VIC 3052, Australia.
  • Cliffe CC; Department of Paediatrics, University of Melbourne, Parkville, VIC 3052, Australia.
  • Madelli EO; Bruce Lefroy Centre, Murdoch Children's Research Institute, Parkville, VIC 3052, Australia.
  • Ho G; Murdoch Children's Research Institute, Parkville, VIC 3052, Australia.
  • Liebelt J; Department of Paediatrics, University of Melbourne, Parkville, VIC 3052, Australia.
  • Long JC; Australian Genomics, Parkville, VIC 3052, Australia.
  • Braithwaite J; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.
  • Kennedy J; Victorian Comprehensive Cancer Centre, Melbourne, VIC 3000, Australia.
  • Massie J; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC 3000, Australia.
  • Emery JD; Victorian Clinical Genetics Services, Parkville, VIC 3052, Australia.
  • McGaughran J; Murdoch Children's Research Institute, Parkville, VIC 3052, Australia.
  • Marum JE; Department of Paediatrics, University of Melbourne, Parkville, VIC 3052, Australia.
  • Boggs K; Sydney Genome Diagnostics, The Children's Hospital at Westmead, Westmead, NSW 2145, Australia.
  • Barlow-Stewart K; Specialty of Genomic Medicine, The Children's Hospital at Westmead Clinical School, Faculty of Medicine and Health, University of Sydney, Westmead, NSW 2145, Australia.
  • Burnett L; NSW Health Pathology Randwick Genomics Laboratory, Randwick, NSW 2031, Australia.
  • Dive L; Murdoch Children's Research Institute, Parkville, VIC 3052, Australia.
  • Freeman L; Australian Genomics, Parkville, VIC 3052, Australia.
  • Davis MR; Sydney Genome Diagnostics, The Children's Hospital at Westmead, Westmead, NSW 2145, Australia.
  • Downes MJ; Specialty of Genomic Medicine, The Children's Hospital at Westmead Clinical School, Faculty of Medicine and Health, University of Sydney, Westmead, NSW 2145, Australia.
  • Wallis M; South Australian Clinical Genetics Service, North Adelaide, SA 5006, Australia.
  • Ferrie MM; Women's and Children's Hospital, North Adelaide, SA 5006, Australia.
  • Pachter N; Repromed, Dulwich, SA 5065, Australia.
  • Scuffham PA; Australian Institute of Health Innovation, Macquarie University, North Ryde, NSW 2109, Australia.
  • Casella R; Australian Genomics, Parkville, VIC 3052, Australia.
  • Allcock RJN; Australian Institute of Health Innovation, Macquarie University, North Ryde, NSW 2109, Australia.
  • Ong R; International Society for Quality in Health Care, D02 YY23 Dublin, Ireland.
  • Edwards S; Genetic Services of Western Australia, Subiaco, WA 6008, Australia.
  • Righetti S; Murdoch Children's Research Institute, Parkville, VIC 3052, Australia.
  • Lunke S; Department of Paediatrics, University of Melbourne, Parkville, VIC 3052, Australia.
  • Lewis S; Department of Respiratory Medicine, The Royal Children's Hospital, Parkville, VIC 3052, Australia.
  • Walker SP; Department of General Practice and Centre for Cancer Research, University of Melbourne, Melbourne, VIC 3000, Australia.
  • Boughtwood TF; Genetic Health Queensland, Royal Brisbane and Women's Hospital, Herston, QLD 4006, Australia.
  • Hardy T; School of Medicine, University of Queensland, St Lucia, QLD 4072, Australia.
  • Newson AJ; Victorian Clinical Genetics Services, Parkville, VIC 3052, Australia.
  • Kirk EP; Australian Genomics, Parkville, VIC 3052, Australia.
  • Laing NG; Centre for Clinical Genetics, Sydney Children's Hospital, Randwick, NSW 2031, Australia.
  • Delatycki MB; Department of Clinical Genetics, The Children's Hospital at Westmead, Westmead, NSW 2145, Australia.
  • The Mackenzie's Mission Study Team; Northern Clinical School, Faculty of Medicine and Health, University of Sydney, St Leonards, NSW 2065, Australia.
J Pers Med ; 12(11)2022 Oct 28.
Article em En | MEDLINE | ID: mdl-36579509
ABSTRACT
Reproductive genetic carrier screening (RGCS) provides people with information about their chance of having children with autosomal recessive or X-linked genetic conditions, enabling informed reproductive decision-making. RGCS is recommended to be offered to all couples during preconception or in early pregnancy. However, cost and a lack of awareness may prevent access. To address this, the Australian Government funded Mackenzie's Mission­the Australian Reproductive Genetic Carrier Screening Project. Mackenzie's Mission aims to assess the acceptability and feasibility of an easily accessible RGCS program, provided free of charge to the participant. In study Phase 1, implementation needs were mapped, and key study elements were developed. In Phase 2, RGCS is being offered by healthcare providers educated by the study team. Reproductive couples who provide consent are screened for over 1200 genes associated with >750 serious, childhood-onset genetic conditions. Those with an increased chance result are provided comprehensive genetic counseling support. Reproductive couples, recruiting healthcare providers, and study team members are also invited to complete surveys and/or interviews. In Phase 3, a mixed-methods analysis will be undertaken to assess the program outcomes, psychosocial implications and implementation considerations alongside an ongoing bioethical analysis and a health economic evaluation. Findings will inform the implementation of an ethically robust RGCS program.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article